Infed

Infed Manufacturers

• General Injectables & Vaccines, Inc
  

  ×

  Infed | General Injectables & Vaccines, Inc

  

  ---

  Oral iron should be discontinued prior to administration of INFeD.

  Dosage:
  I. Iron Deficiency Anemia: Periodic hematologic determination (hemoglobin and hematocrit) is a simple and accurate technique for monitoring hematological response, and should be used as a guide in therapy. It should be recognized that iron storage may lag behind the appearance of normal blood morphology. Serum iron, total iron binding capacity (TIBC) and percent saturation of transferrin are other important tests for detecting and monitoring the iron deficient state. After administration of iron dextran complex, evidence of a therapeutic response can be seen in a few days as an increase in the reticulocyte count. Although serum ferritin is usually a good guide to body iron stores, the correlation of body iron stores and serum ferritin may not be
  valid in patients on chronic renal dialysis who are also receiving iron dextran complex. Although there are significant variations in body build and weight distribution among males and females, the accompanying table and formula represent a convenient means for estimating the total iron required. This total iron requirement reflects the amount of iron needed to restore hemoglobin concentration to normal or near normal levels plus an additional allowance to provide adequate replenishment of iron stores in most individuals with moderately or severely reduced levels of hemoglobin. It should be remembered that iron deficiency anemia will not appear until essentially all iron stores have been depleted. Therapy, thus, should aim at not only replenishment of hemoglobin iron but iron stores as well.
  Factors contributing to the formula are shown below.

  mg blood iron  =   mL blood   x    g hemoglobin  x  mg iron
  lb body weight    lb body weight    mL blood          g hemoglobin
  

  1. Blood volume . . . . . . . . . . . . . . . .65 mL/kg of body weight
  2. Normal hemoglobin (males and females)
  over 15 kg (33 lbs) . . . . . . . . . . . .14.8 g/dl
  15 kg (33 lbs) or less . . . . . . . . . .12.0 g/dl
  3. Iron content of hemoglobin . . . . . 0.34%
  4. Hemoglobin deficit
  5. Weight
  Based on the above factors, individuals with normal hemoglobin levels will have approximately 33 mg of blood iron per kilogram of body weight (15 mg/lb).
  Note: The table and accompanying formula are applicable for dosage determinations only in patients with iron deficiency anemia; they are not to be used for dosage determinations in patients requiring iron replacement for blood loss.
  TOTAL INFeD REQUIREMENT FOR HEMOGLOBIN RESTORATION AND IRON STORES REPLACEMENT*

  Patient Lean
  Body Weight
  Milliliter Requirement
  of INFeD Based on
  Observed Hemoglobin
   of
  
  
  
  
  
  
  kg
  lb
  3
  (g/dl)
  4
  (g/dl)
  5
  (g/dl)
  6
  (g/dl)
  7
  (g/dl)
  8
  (g/dl)
  9
  (g/dl)
  10
  (g/dl)
  5
  11
  3
  3
  3
  3
  2
  2
  2
  2
  10
  22
  7
  6
  6
  5
  5
  4
  4
  3
  15
  33
  10
  9
  9
  8
  7
  7
  6
  5
  20
  44
  16
  15
  14
  13
  12
  11
  10
  9
  25
  55
  20
  18
  17
  16
  15
  14
  13
  12
  30
  66
  23
  22
  21
  19
  18
  17
  15
  14
  35
  77
  27
  26
  24
  23
  21
  20
  18
  17
  40
  88
  31
  29
  28
  26
  24
  22
  21
  19
  45
  99
  35
  33
  31
  29
  27
  25
  23
  21
  50
  110
  39
  37
  35
  32
  30
  28
  26
  24
  55
  121
  43
  41
  38
  36
  33
  31
  28
  26
  60
  132
  47
  44
  42
  39
  36
  34
  31
  28
  65
  143
  51
  48
  45
  42
  39
  36
  34
  31
  70
  154
  55
  52
  49
  45
  42
  39
  36
  33
  75
  165
  59
  55
  52
  49
  45
  42
  39
  35
  80
  176
  63
  59
  55
  52
  48
  45
  41
  38
  85
  187
  66
  63
  59
  55
  51
  48
  44
  40
  90
  198
  70
  66
  62
  52
  54
  50
  46
  42
  95
  209
  74
  70
  66
  62
  57
  53
  49
  45
  100
  220
  78
  74
  69
  65
  60
  56
  52
  47
  105
  231
  82
  77
  73
  68
  63
  59
  54
  50
  110
  242
  86
  81
  76
  71
  67
  62
  57
  52
  115
  253
  90
  85
  80
  75
  70
  64
  59
  54
  120
  264
  94
  88
  83
  78
  73
  67
  62
  57
  *Table values were calculated based on a normal adult hemoglobin of 14.8 g/dl for weights greater than 15 kg (33 lbs) and a hemoglobin of 12.0 g/dl for weights less than or equal to 15 kg (33 lbs).
  The total amount of INFeD in mL required to treat the anemia and replenish iron stores may be approximated as follows:
  Adults and Children over 15 kg (33 lbs): See Dosage Table. Alternatively the total dose may be calculated:
  Dose (mL) = 0.0442 (Desired Hb - Observed Hb) x LBW + (0.26 x LBW)
  Based on: Desired Hb = the target Hb in g/dl.
  Observed Hb = the patient’s current hemoglobin in g/dl.
  LBW = Lean body weight in kg. A patient’s lean body weight (or actual body weight if less than lean body weight) should be utilized when determining dosage.
  For males: LBW = 50 kg + 2.3 kg for each inch of patient’s height over 5 feet
  For females: LBW = 45.5 kg + 2.3 kg for each inch of patient’s height over 5 feet
  To calculate a patient's weight in kg when lbs are known:
  
  
  patient's weight in kilograms = weight in kilograms
                   2.2
  
  Children 5 - 15 kg (11 - 33 lbs): See Dosage Table.
  INFeD should not normally be given in the first four months of life. (See PRECAUTIONS: Pediatric Use.)
  Alternatively the total dose may be calculated:
  Dose (mL) = 0.0442 (Desired Hb - Observed Hb) x W + (0.26 x W)
  Based on: Desired Hb = the target Hb in g/dl. (Normal Hb for Children 15 kg or less is 12 g/dl)
  W = Weight in kg.
  To calculate a patient's weight in kg when lbs are known:
  
  
  patient's weight in kilograms = weight in kilograms
                   2.2
  
  II. Iron Replacement for Blood Loss: Some individuals sustain blood losses on an intermittent or repetitive basis. Such blood losses may occur periodically in patients with hemorrhagic diatheses (familial telangiectasia; hemophilia; gastrointestinal bleeding) and on a repetitive basis from procedures such as renal hemodialysis. Iron therapy in these patients should be directed toward replacement of the equivalent amount of iron represented in the blood loss. The table and formula described under I. Iron Deficiency Anemia are not applicable for simple iron replacement values. Quantitative estimates of the individual’s periodic blood loss and hematocrit during the bleeding episode provide a convenient method for the calculation of the required iron dose. The formula shown below is based on the approximation that 1 mL of normocytic, normochromic red cells contains 1 mg of elemental iron:
  
  Replacement iron (in mg) = Blood loss (in mL) x hematocrit
  Example: Blood loss of 500 mL with 20% hematocrit
  Replacement Iron = 500 x 0.20 = 100 mg
  INFeD dose = 100 mg = 2 mL
                          50
  Administration:
  The total amount of INFeD required for the treatment of iron deficiency anemia or iron replacement for blood loss is determined from the table or appropriate formula. (See Dosage).
  I. Intravenous Injection - PRIOR TO THE FIRST INTRAVENOUS INFeD THERAPEUTIC DOSE, ADMINISTER AN INTRAVENOUS TEST DOSE OF 0.5 ML. ADMINISTER THE TEST DOSE AT A GRADUAL RATE OVER AT LEAST 30 SECONDS. Although anaphylactic reactions known to occur following INFeD administration are usually evident within a few minutes, or sooner, it is recommended that a period of an hour or longer elapse before the remainder of the initial therapeutic dose is given. Individual doses of 2 mL or less may be given on a daily basis until the calculated total amount required has been reached. INFeD is given undiluted at a slow gradual rate not to exceed 50 mg (1 mL) per minute.
  2. Intramuscular Injection - PRIOR TO THE FIRST INTRAMUSCULAR INFeD THERAPEUTIC DOSE, ADMINISTER AN INTRAMUSCULAR TEST DOSE OF 0.5 ML. (See BOXED WARNING and PRECAUTIONS.) The test dose should be administered in the buttock using the same technique as described in the last paragraph of this section. Although anaphylactic reactions known to occur following INFeD administration are usually evident within a few minutes or sooner, it is recommended that at least an hour or longer elapse before the remainder of the initial therapeutic dose is given. If no adverse reactions are observed, INFeD can be given according to the following schedule until the calculated total amount required has been reached. Each day’s dose should ordinarily not exceed 0.5 mL (25 mg of iron) for infants under 5 kg (11 lbs); 1.0 mL (50 mg of iron) for children under 10 kg (22 lbs); and 2.0 mL (100 mg of iron) for other patients. INFeD should be injected only into the muscle mass of the upper outer quadrant of the buttock - never into the arm or other exposed areas - and should be injected deeply, with a 2-inch or 3-inch 19 or 20 gauge needle. If the patient is standing, he/she should be bearing his/her weight on the leg opposite the injection site, or if in bed, he/she should be in the lateral position with injection site uppermost. To avoid injection or leakage into the subcutaneous tissue, a Z-track technique (displacement of the skin laterally prior to injection) is recommended.
  NOTE: Do not mix INFeD with other medications or add to parenteral nutrition solutions for intravenous infusion. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit.
  

  Close
  No Recall

  More Info
• Actavis Pharma, Inc.
  

  ×

  Infed | Actavis Pharma, Inc.

  

  ---

  Oral iron should be discontinued prior to administration of INFeD.

  Dosage:

  I. Iron Deficiency Anemia:  Periodic hematologic determination (hemoglobin and hematocrit) is a simple and accurate technique for monitoring hematological response, and should be used as a guide in therapy. It should be recognized that iron storage may lag behind the appearance of normal blood morphology. Serum iron, total iron binding capacity (TIBC) and percent saturation of transferrin are other important tests for detecting and monitoring the iron deficient state.

  After administration of iron dextran complex, evidence of a therapeutic response can be seen in a few days as an increase in the reticulocyte count.

  Although serum ferritin is usually a good guide to body iron stores, the correlation of body iron stores and serum ferritin may not be valid in patients on chronic renal dialysis who are also receiving iron dextran complex.

  Although there are significant variations in body build and weight distribution among males and females, the accompanying table and formula represent a convenient means for estimating the total iron required. This total iron requirement reflects the amount of iron needed to restore hemoglobin concentration to normal or near normal levels plus an additional allowance to provide adequate replenishment of iron stores in most individuals with moderately or severely reduced levels of hemoglobin. It should be remembered that iron deficiency anemia will not appear until essentially all iron stores have been depleted. Therapy, thus, should aim at not only replenishment of hemoglobin iron but iron stores as well.

  Factors contributing to the formula are shown below.
  
  

  Blood volume . . . . . . . . . . . . . . . .65 mL/kg of body weight Normal hemoglobin (males and females) 
  over 15 kg (33 lbs) . . . . . . . . . . . .14.8 g/dl
  15 kg (33 lbs) or less . . . . . . . . . .12.0 g/dl Iron content of hemoglobin . . . . .   0.34% Hemoglobin deficit Weight

  Based on the above factors, individuals with normal hemoglobin levels will have approximately 33 mg of blood iron per kilogram of body weight (15 mg/lb).

  Note: The table and accompanying formula are applicable for dosage determinations only in patients with iron deficiency anemia; they are not to be used for dosage determinations in patients requiring iron replacement for blood loss.

  TOTAL INFeD REQUIREMENT FOR HEMOGLOBIN RESTORATION AND IRON STORES REPLACEMENT* PATIENT
   LEAN BODY
   WEIGHT Milliliter Requirement of INFeD Based On Observed
  Hemoglobin of  kg  lb  3
  (g/dl)  4
  (g/dl)  5
  (g/dl)  6
  (g/dl)  7
  (g/dl)  8
  (g/dl)  9
  (g/dl) 10
  (g/dl)  5  11  3  3  3  3  2  2  2  2  10  22  7  6  6  5  5  4  4  3  15  33  10  9  9  8  7  7  6  5  20  44  16  15  14  13  12  11  10  9  25  55  20  18  17  16  15  14  13  12  30  66  23  22  21  19  18  17  15  14  35  77  27  26  24  23  21  20  18  17  40  88  31  29  28  26  24  22  21  19  45  99  35  33  31  29  27  25  23  21  50  110  39  37  35  32  30  28  26  24  55  121  43  41  38  36  33  31  28  26  60  132  47  44  42  39  36  34  31  28  65  143  51  48  45  42  39  36  34  31  70  154  55  52  49  45  42  39  36  33  75  165  59  55  52  49  45  42  39  35  80  176  63  59  55  52  48  45  41  38  85  187  66  63  59  55  51  48  44  40  90  198  70  66  62  58  54  50  46  42  95  209  74  70  66  62  57  53  49  45  100  220  78  74  69  65  60  56  52  47  105  231  82  77  73  68  63  59  54  50  110  242  86  81  76  71  67  62  57  52  115  253  90  85  80  75  70  64  59  54  120  264  94  88  83  78  73  67  62  57

  *Table values were calculated based on a normal adult hemoglobin of 14.8 g/dl for weights greater than 15 kg (33 lbs) and a hemoglobin of 12.0 g/dl for weights less than or equal to 15 kg (33 lbs).

  The total amount of INFeD in mL required to treat the anemia and replenish iron stores may be approximated as follows:

  Adults and Children over 15 kg (33 lbs): See Dosage Table. Alternatively the total dose may be calculated:

  Dose (mL) = 0.0442 (Desired Hb - Observed Hb) x LBW + (0.26 x LBW)
  Based on: Desired Hb = the target Hb in g/dl.
  Observed Hb = the patient’s current hemoglobin in g/dl.
  LBW = Lean body weight in kg. A patient’s lean body weight (or actual body weight if less than lean body weight) should be utilized when determining dosage.
  For males: LBW = 50 kg + 2.3 kg for each inch of patient’s height over 5 feet
  For females: LBW = 45.5 kg + 2.3 kg for each inch of patient’s height over 5 feet
  To calculate a patient's weight in kg when lbs are known:

   

  Children 5 - 15 kg (11 - 33 lbs):  See Dosage Table.

  INFeD should not normally be given in the first four months of life. (See PRECAUTIONS: Pediatric Use.)
  Alternatively the total dose may be calculated:
  Dose (mL) = 0.0442 (Desired Hb - Observed Hb) x W + (0.26 x W)
  Based on: Desired Hb = the target Hb in g/dl. (Normal Hb for Children 15 kg or less is 12 g/dl)
  W = Weight in kg.
  To calculate a patient's weight in kg when lbs are known:
  
   

  II.  Iron Replacement for Blood Loss: Some individuals sustain blood losses on an intermittent or repetitive basis. Such blood losses may occur periodically in patients with hemorrhagic diatheses (familial telangiectasia; hemophilia; gastrointestinal bleeding) and on a repetitive basis from procedures such as renal hemodialysis.

  Iron therapy in these patients should be directed toward replacement of the equivalent amount of iron represented in the blood loss. The table and formula described under I.  Iron Deficiency Anemia are not applicable for simple iron replacement values.

  Quantitative estimates of the individual’s periodic blood loss and hematocrit during the bleeding episode provide a convenient method for the calculation of the required iron dose.

  The formula shown below is based on the approximation that 1 mL of normocytic, normochromic red cells contains 1 mg of elemental iron:
  Replacement iron (in mg) = Blood loss (in mL) x hematocrit
  Example: Blood loss of 500 mL with 20% hematocrit
                  Replacement Iron = 500 x 0.20 = 100 mg
                  INFeD dose = 100 mg = 2 mL
                                              50

  Administration:

  The total amount of INFeD required for the treatment of iron deficiency anemia or iron replacement for blood loss is determined from the table or appropriate formula. (See Dosage).

  I.  Intravenous Injection - PRIOR TO THE FIRST INTRAVENOUS INFeD THERAPEUTIC DOSE, ADMINISTER AN INTRAVENOUS TEST DOSE OF 0.5 ML. ADMINISTER THE TEST DOSE AT A GRADUAL RATE OVER AT LEAST 30 SECONDS. Although anaphylactic reactions known to occur following INFeD administration are usually evident within a few minutes, or sooner, it is recommended that a period of an hour or longer elapse before the remainder of the initial therapeutic dose is given.

  Individual doses of 2 mL or less may be given on a daily basis until the calculated total amount required has been reached. INFeD is given undiluted at a slow gradual rate not to exceed 50 mg (1 mL) per minute.

  2.  Intramuscular Injection -  PRIOR TO THE FIRST INTRAMUSCULAR INFeD THERAPEUTIC DOSE, ADMINISTER AN INTRAMUSCULAR TEST DOSE OF 0.5 ML. (See BOXED WARNING  and PRECAUTIONS.) The test dose should be administered in the buttock using the same technique as described in the last paragraph of this section. Although anaphylactic reactions known to occur following INFeD administration are usually evident within a few minutes or sooner, it is recommended that at least an hour or longer elapse before the remainder of the initial therapeutic dose is given.

  If no adverse reactions are observed, INFeD can be given according to the following schedule until the calculated total amount required has been reached. Each day’s dose should ordinarily not exceed 0.5 mL (25 mg of iron) for infants under 5 kg (11 lbs); 1.0 mL (50 mg of iron) for children under 10 kg (22 lbs); and 2.0 mL (100 mg of iron) for other patients.

  INFeD should be injected only into the muscle mass of the upper outer quadrant of the buttock - never into the arm or other exposed areas - and should be injected deeply, with a 2-inch or 3-inch 19 or 20 gauge needle. If the patient is standing, he/she should be bearing his/her weight on the leg opposite the injection site, or if in bed, he/she should be in the lateral position with injection site uppermost. To avoid injection or leakage into the subcutaneous tissue, a Z-track technique (displacement of the skin laterally prior to injection) is recommended.

  NOTE:  Do not mix INFeD with other medications or add to parenteral nutrition solutions for intravenous infusion.

  Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit.

  Close
  No Recall

  More Info